Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of ...

Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.

After layoffs at Recursion, the company’s CEO writes about taking inspiration from an unexpected source: “The Art of Racing ...

Recursion Pharmaceuticals said on Tuesday it will lay off around 20% of its workforce and focus on developing drugs for rare diseases and cancers to reduce cash burn during a prolonged biotech ...

Based on its latest expense profile and business plan, after cutting its staff, Recursion said it now expects its projected cash runway to extend into the fourth quarter of 2027. Recursion will pay ...

Over the last 10 years, breakthroughs in understanding the genetic instructions passed from parent to offspring have put ...

Santosh Ratna Deepika Addagalla is a healthcare tech leader and FHIR & cloud architecture expert at Trizetto Provider ...

allowing users to assemble algorithms from algorithm building blocks. This paper provides a comparison between students' acceptance of both black-box and white-box decision tree algorithms. For these ...

Think is a daily, topic-driven interview and call-in program hosted by Krys Boyd covering a wide variety of topics ranging from history, politics, current events, science, technology and emerging ...